Comment on: Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long‐Term Exposure While Maintaining Efficacy. A Ball Gown That Fits All

Documenti analoghi

• Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long‐Term Exposure While Maintaining Efficacy
  di: Natalia Wojciechowska, et al.
  Pubblicazione: (2025)
• Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
  di: Wenqian Wang, et al.
  Pubblicazione: (2026)
• A Novel Approach to Managing Pulmonary Langerhans Cell Histiocytosis‐Associated Bullae: A Case Report
  di: Laksita Joshi, et al.
  Pubblicazione: (2025)
• Congenital Langerhans Cell Histiocytosis With Novel KLC1::RAF1 Gene Fusion Identified Through Routine Whole‐Genome Sequencing
  di: Fiona E. Wright, et al.
  Pubblicazione: (2025)
• Correction to ‘Congenital Langerhans Cell Histiocytosis With Novel KLC1::RAF1 Gene Fusion Identified Through Routine Whole‐Genome Sequencing’
  Pubblicazione: (2026)